Kantify (@kantify) header
Kantify (@kantify) profile picture

Kantify

@kantify

Kantify uses AI to discover breakthrough therapies that change patients' lives. Our next gen AI platform, Sapian, identifies novel targets and molecules

 Brussels, Belgium
kantify.com
Joined March 2016
  • Tweets715
  • Following433
  • Followers448
128Media
Photo by Kantify (@kantify)Photo by Kantify (@kantify)Photo by Kantify (@kantify)Photo by Kantify (@kantify)Photo by Kantify (@kantify)Photo by Kantify (@kantify)Photo by Kantify (@kantify)Photo by Kantify (@kantify)Photo by Kantify (@kantify)Photo by Kantify (@kantify)
Join us to explore Innovation in Clinical Trials for Rare Diseases with renowned experts! 🗓️ Date: February 28, 2025 🕒 Time: 12:00 PM – 1:30 PM (CET) 🌐 Format: Online (registration: bit.ly/3PSLE3N) #RareDiseaseDay #RareDiseases #DREAMSProject #webinar
Image from Dreams EU Project (@DreamsPjt_EU)
2
1
98
Great to see EU-funded research projects DREAMS with @Xavier_Nissan & @kantify, REPO4EU and certainly others at REXPO24 ! DREAMS: cordis.europa.eu/project/id/… REPO4EU: cordis.europa.eu/project/id/… cordis.europa.eu/search?q=co…
Drug REpurposing with Artificial intelligence for Muscular disorderS | DREAMS | Project | Fact...

Drug REpurposing with Artificial intelligence for Muscular disorderS | DREAMS | Project | Fact...

According to World Health Organization, to date, fewer than 6% of rare diseases (RDs) have an approved treatment option. In the light of this observation, it appears crucial to develop disruptive...

cordis.europa.eu
Kantify (@kantify) profile pictureKantify@kantify5 Jul 2024
Day 3 of REXPO24, Conference on drug repurposing, is today. @Xavier_Nissan, Research Director at i-Stem, presented our common Horizon Europe project DREAMS, DREAMS combines AI and induced Pluripotent Stem Cells (iPSCs) to discover drugs for several rare neuromuscular disorders.
Image from Kantify (@kantify)
Image from Kantify (@kantify)
1
5
134
Proud of DREAMS' dedicated partners and their commitment to advancing groundbreaking findings for treatments using AI. Exciting times indeed! Congratulations to Nik Subramanian and the @Kantify team! 🚀🌟 #REXPO24 #DREAMSProject #AI #RareCancers
Kantify (@kantify) profile pictureKantify@kantify4 Jul 2024
Today, Kantify's CTO Nik Subramanian presented at REXPO, the conference on drug repurposing, some of our novel findings on using Artificial Intelligence to find novel therapeutics targets and drugs for rare cancers! Exciting times.
Image from Kantify (@kantify)
Image from Kantify (@kantify)
1
3
76
We finally managed to synthesize this drug in a very pure form (and good news - it's still as effective). The chemistry side of the project has really required herculean efforts - thank you to my team and our partners for your grit.
Nik Subramanian (@NikSubramanian) profile pictureNik Subramanian@NikSubramanian13 Oct 2023
We got in vitro results today that show that we've found a first-in-class, potent drug that we hope will be able to treat a wide variety of cancers. Took us a couple of months (v. ~3-10 years usually) and tested just 30 compounds (v. 100k+). Still work to do, but screw cancer.
2
7
279
Our brilliant colleague Caio Hudson Queiroz de Souza just clinched his first co-authorship in @NatureMedicine - read more about the clinical trial he helped lead here: nature.com/articles/s41591-0…
1
3
136
Very proud of Dr. @MayaJeitany presenting our groundbreaking collaboration at @myESMO in Lugano. In just 6 months, we've discovered 8 new drug targets and 7 novel repurposable drugs in most (all?) types of liposarcoma, rare cancers with high unmet need. More validations soon!
Dr. Maya Jeitany presenting the results of a collaboration with Kantify.

ALT Dr. Maya Jeitany presenting the results of a collaboration with Kantify.

Image from Nik Subramanian (@NikSubramanian)
1
1
3
151
Very happy to present @DreamsPjt_EU at #iDR24 conference. A big thanks to @REMEDi4ALL for bringing the whole community of drug repurposing together in #Barcelona. 1st day's take home message: The solution will come from 1- patient involvement and 2- public/private collaborations
Image from Xavier Nissan (@Xavier_Nissan)
Image from Xavier Nissan (@Xavier_Nissan)
4
2
12
776
Proud to be part of this ambitious project! We're working on using @kantify 's AI-based drug discovery platform to find treatments for multiple neuromuscular disorders characterized by dysregulations of autophagy. Give the project a follow!
Dreams EU Project (@DreamsPjt_EU) profile pictureDreams EU Project@DreamsPjt_EU26 Feb 2024
Exciting news📢: @DreamsPjt_EU, backed by #HorizonEurope, pioneers neuromuscular disease treatment through #AI, stem cells, and advanced pharmacology, aiming to address five #RareDiseases impacting 400,000+ globally. 🔬Follow us for further insights!
Image from Dreams EU Project (@DreamsPjt_EU)
2
4
262
🔬Belgium is a global #biopharma hub w/ innovative research, strategic partnerships & strong education creating sustainable growth & future-proof developments. 🇧🇪 Today @BelgiumDGB organised the “Belgium's Biopharmaceutical Excellence” conference, bringing together stakeholders.
Image from 🇧🇪 Belgium MFA (@BelgiumMFA)
1
12
2
31
3,661
Maladies rares : une start-up belge va combiner IA et biologie de pointe pour accélérer la découverte de médicaments lalibre.be/economie/entrepri… @kantify
2
2
5
528
"95% of rare diseases don't have a treatment, and here's how the AI we are developing is helping solve this problem." Kantify's CEO, @Segozone, on national tv auvio.rtbf.be/live/declic-47…
Image from Nik Subramanian (@NikSubramanian)
3
1
184
Kantify retweeted
Bart Collet (@bart) profile picture
Bart Collet
@bart24 May 2023
😍 Healthtech @tech_eu @kantify using #AI to discover new therapies #techeu23
Image from Bart Collet (@bart)
1
4
286
“Our ambition is to build a bridge between biotech and AI”. And from this, fulfill our core mission : improve human health 🫶🏽 Many thanks @Xavier_Nissan and @IStemFrance for embarking us into this adventure! 💊 #drugdiscovery #stemcells #artificialintelligence
Lovens Pierre-François (@pflovens_) profile pictureLovens Pierre-François@pflovens_28 Apr 2022
Grâce à l'intelligence artificielle, la start-up belge Kantify accélère la découverte de médicaments - lalibre.be/economie/entrepri… @kantify @LaLibreEco @Segozone
1
2
Et ce n'est que le début ! D'autres succès ne tarderont pas !
flanders.bio (@flandersbio) profile pictureflanders.bio@flandersbio28 Apr 2022
Kantify and I-Stem announced a successful collaboration on using Artificial Intelligence and report the discovery of a new therapy for an uncured rare neuromuscular disease. bit.ly/39gYN4F
flanders.bio member news - Kantify

ALT flanders.bio member news - Kantify

2
4
Kantify and I-Stem announced a successful collaboration on using Artificial Intelligence and report the discovery of a new therapy for an uncured rare neuromuscular disease. bit.ly/39gYN4F
flanders.bio member news - Kantify

ALT flanders.bio member news - Kantify

3
1
3
Très fier de ce travail publié dans @FrontPharmacol! Fruit d'une collaboration entre @IStemFrance, @GenethonFr et @kantify nous y mettons en évidence l'effet d'un traitement à deux #LGMD. Un projet qui combine #Criblage et #IA financé grâce aux dons du @Telethon_France. MERCI🙏
Image from Xavier Nissan (@Xavier_Nissan)
AFM-Téléthon PRESSE (@AfmPresse) profile pictureAFM-Téléthon PRESSE@AfmPresse27 Apr 2022
Replying to @AfmPresse
"Un projet innovant combinant nos expertises et les technologies de criblage et d’intelligence artificielle. Valider l'approche en pré-clinique est la prochaine étape dans l’objectif de lancer un essai clinique" @Xavier_Nissan dir recherche @IStemFrance ➕bit.ly/3KmCOGp
Image from AFM-Téléthon PRESSE (@AfmPresse)
2
12
11
💊Would you like to know more about novel #AI applications for #drug discovery and development? @kantify is organizing a virtual event on this topic as part of #EBW2021. ➡️Find out more and register here: cutt.ly/vWYqQRc #biotech #healthcare #research #pharmaceutical
4
3
Participating in the launch of the Global Partnership on AI today. Honored to be nominated as an expert in the WG on Innovation and Commercialization. 27 experts from many countries discussing the key issue of AI and Innovation. #GPAI
2
1
8
Conversation: Artificial Intelligence in the EU--What are the bottlenecks for SMEs? pscp.tv/w/cXlhEjFXZ0tnYWdKen…
5
2
8
🎉 We’re thrilled to announce our first speaker for #databeers #brussels no14: @Segozone @kantify with “From heart to diagnosis: When AI predicts health” 😊 We missed her last time, & are so happy she can make it this time! Tickets go live 30/1 at 17h 👉 eventbrite.com/e/databeers-b…
Image from DataBeers Brussels (@DataBeersBru)
5
1
11
Load more